3 Tech Adoption Rules for Health Systems to Follow

2023-04-03
AHA会议
Hospitals’ finances remain incredibly tight as they continue to battle the rising costs of labor and supplies. New technology can help providers improve operational efficiency and alleviate clinician burnout, but hospitals don’t have much money to invest in shiny new solutions at the moment. Not surprisingly, hospitals are being more careful than ever when scrutinizing the return on investment for new technology. To weed out the not-so-promising solutions from the plethora of options available, Ashis Barad — who recently became Allegheny Health Network’s new chief information and digital officer — gave three pieces of advice during an interview last week at ViVE, a healthcare innovation conference in Nashville. Don’t waste too much time on companies that can’t clearly articulate the problem they’re seeking to solve. Barad, who spent years as a digital health executive at Baylor White & Scott Health before switching to Allegheny, has taken countless meetings with vendors keen to sell their products to hospitals. Sometimes, he has found himself in a situation where “we’re three meetings in and they still have not been able to eloquently tell me what their tool is actually trying to solve,” he said. If a company can’t be clear about the fundamental issue it is tackling, it makes it much more difficult to answer the questions that come next, such as inquiries about workflow integration and scalability. Fogginess about the core problem at hand can also make ROI calculation difficult. If a company can’t communicate the pain point on which it is focused, it makes it hard for health system executives to pinpoint which metrics to track to determine if their investment is worth it. View Big Tech as potential partners — not threats. Big Tech companies like Amazon, Microsoft and Google are moving further into the healthcare sector, and Barad views these disruptors through a partnership lens rather than a competitive lens, he declared. “I look at what they’re doing in the space, and as they evolve, I don’t think that they really want to get into the game of offering the full breadth of healthcare services. I just don’t see that, so I think that there’s a lot of capacity to partner with them,” Barad said. Big Tech companies aren’t seeking to replace traditional healthcare providers, and they aren’t saying that they can deliver care better than hospitals can. In Barad’s view, they’re simply trying to help the traditional healthcare system solve decades-long pain points through technology. Through partnerships, both providers and Big Tech companies can focus on what they’re good at. Providers can focus on providing quality care and increasing access, while Big Tech companies can work with them to co-develop user-friendly tech stacks and solutions for better data management. When developing or adopting new technology, make sure clinicians are involved. If a technology doesn’t seamlessly fit into a clinician’s existing workflow, they won’t use it, Barad pointed out. That’s why the C-suite shouldn’t make decisions about which technology to roll out across their enterprise without consulting the clinicians who will end up using the solution. “Having a clinical leader that understands technology and clinical workflows involved early in the design phase is something that I think a lot of health systems are still working on,” he declared.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。